Nanocarrier-Based Approaches for Enhanced Management of Androgenetic Alopecia: Advancements and Future Prospects

    PRITAM KAYAL, R. RAGHUL, UDAYA KIRAN SAHOO, Nagarjun Jawahar
    TLDR Nanocarriers could improve hair loss treatments by delivering drugs directly to hair follicles.
    The document explores the use of nanocarrier-based approaches to enhance the management of Androgenetic Alopecia (AGA), highlighting the limitations of current treatments like Finasteride and Minoxidil. Nanocarriers, such as liposomes and polymeric nanoparticles, offer targeted drug delivery, improving drug stability and bioavailability while minimizing systemic exposure. These technologies can deliver treatments directly to hair follicles, potentially improving outcomes. Despite promising preclinical results, challenges like limited clinical trials and regulatory issues must be overcome for clinical application. The review underscores the potential of nanotechnology in AGA treatment and calls for further clinical validation and scalable production methods.
    Discuss this study in the Community →

    Research cited in this study

    52 / 52 results

    Related Community Posts Join

    3 / 3 results

    Similar Research

    5 / 447 results